| scholarly article | Q13442814 |
| P2093 | author name string | Farideh Zafari Zangeneh | |
| Mohammad Mehdi Naghizadeh | |||
| Masoumeh Masoumi | |||
| P2860 | cites work | Polycystic ovary syndrome | Q80844876 |
| Mediators of inflammation in polycystic ovary syndrome in relation to adiposity | Q21296837 | ||
| The interleukin-17 cytokine family: critical players in host defence and inflammatory diseases | Q24594675 | ||
| Adrenergic regulation of innate immunity: a review | Q26796227 | ||
| Inflammation in Polycystic Ovary Syndrome: underpinning of insulin resistance and ovarian dysfunction | Q27011541 | ||
| Noradrenaline induces IL-1ra and IL-1 type II receptor expression in primary glial cells and protects against IL-1beta-induced neurotoxicity | Q28568597 | ||
| Modulation by cytokines of glucocorticoid action. | Q33692675 | ||
| Preventing granulosa cell apoptosis through the action of a single microRNA | Q34008319 | ||
| Locus coeruleus lesions and PCOS: role of the central and peripheral sympathetic nervous system in the ovarian function of rat | Q34176488 | ||
| Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). | Q34285382 | ||
| Regulation of the hypothalamic-pituitary-adrenal axis by cytokines: actions and mechanisms of action | Q34489760 | ||
| Treatment options for polycystic ovary syndrome | Q34574136 | ||
| Th1/Th17 plasticity is a marker of advanced β cell autoimmunity and impaired glucose tolerance in humans | Q34756902 | ||
| Insulin resistance and chronic cardiovascular inflammatory syndrome | Q35146311 | ||
| The importance of insulin resistance in polycystic ovary syndrome | Q35196447 | ||
| The sympathetic nervous response in inflammation | Q35413675 | ||
| The molecular-genetic basis of functional hyperandrogenism and the polycystic ovary syndrome. | Q35961894 | ||
| Apoptosis in the ovary: molecular mechanisms | Q36038018 | ||
| Neurosteroids, trigger of the LH surge | Q36328202 | ||
| Release of norepinephrine in the preoptic area activates anteroventral periventricular nucleus neurons and stimulates the surge of luteinizing hormone | Q36486130 | ||
| Hypothalamic PI3K and MAPK differentially mediate regional sympathetic activation to insulin | Q37486718 | ||
| The role of low-grade inflammation in the polycystic ovary syndrome | Q37779835 | ||
| The sympathetic nervous system in polycystic ovary syndrome: a novel therapeutic target? | Q38033647 | ||
| Mediators of low-grade chronic inflammation in polycystic ovary syndrome (PCOS). | Q38085397 | ||
| Inflammation amplifier, a new paradigm in cancer biology | Q38173304 | ||
| IL-17 cytokines in immunity and inflammation | Q38514251 | ||
| The Emerging Role of Chronic Low-Grade Inflammation in the Pathophysiology of Polycystic Ovary Syndrome. | Q38541539 | ||
| Regulation of IL-17 family members by adrenal hormones during experimental sepsis in mice | Q39693257 | ||
| Increased sympathetic reactivity may predict insulin resistance: an 18-year follow-up study | Q40045018 | ||
| On a Difference in the Influence upon Inflammation between the Section of the Sympathetic Nerve and the Removal of the sympathetic Ganglion. | Q41035976 | ||
| Luteinizing hormone up-regulates the expression of interleukin-1 beta mRNA in human granulosa-luteal cells | Q42485611 | ||
| Interleukin-1 alpha and -beta modulation of luteinized human granulosa cell oestrogen and progesterone biosynthesis | Q42523812 | ||
| Noradrenaline acting at beta-adrenoceptors induces expression of IL-1beta and its negative regulators IL-1ra and IL-1RII, and drives an overall anti-inflammatory phenotype in rat cortex | Q43110959 | ||
| Luteinizing hormone and luteinizing hormone-releasing hormone secretion is under locus coeruleus control in female rats. | Q44207400 | ||
| In vivo and in vitro effects of interleukin-1beta on equine oocyte maturation and on steroidogenesis and prostaglandin synthesis in granulosa and cumulus cells | Q46124986 | ||
| Is polycystic ovary syndrome associated with high sympathetic nerve activity and size at birth? | Q46806032 | ||
| Effects of interleukin-1 beta fragment (163-171) on progesterone and estradiol-17 beta release by bovine granulosa cells from different size follicles | Q47319623 | ||
| Inhibition of in vitro maturation of equine oocytes by interleukin 1 beta via specific IL-1 receptors | Q47587988 | ||
| Contribution of central and peripheral adrenergic stimulation to IL-1 alpha-mediated glucoregulation | Q48092606 | ||
| Cytokine-specific central monoamine alterations induced by interleukin-1, -2 and -6. | Q48139231 | ||
| Noradrenergic innervation of the hypothalamus participates in adrenocortical responses to interleukin-1. | Q48457521 | ||
| Locus coeruleus lesions decrease norepinephrine input into the medial preoptic area and medial basal hypothalamus and block the LH, FSH and prolactin preovulatory surge | Q48595609 | ||
| Cytokines as modulators of the hypothalamus-pituitary-adrenal axis | Q48829804 | ||
| The proinflammatory cytokine, interleukin-17A, augments mitochondrial function and neurite outgrowth of cultured adult sensory neurons derived from normal and diabetic rats. | Q53362170 | ||
| IL-1 receptor antagonist levels are associated with glucose tolerance in polycystic ovary syndrome. | Q53790585 | ||
| Peripheral administration of interleukin-1 increases extracellular concentrations of norepinephrine in rat hypothalamus: comparison with plasma corticosterone | Q71460837 | ||
| Interleukin-1 stimulates luteinizing hormone release during the midfollicular phase in the rhesus monkey: a novel way in which stress may influence the menstrual cycle | Q71886447 | ||
| Interleukin-1beta (IL-1beta) is a modulator of human luteal cell steroidogenesis: localization of the IL type I system in the corpus luteum | Q73194350 | ||
| Interrelationships between Immune and Reproductive Systems in Human | Q73248001 | ||
| Interleukin-1 alpha but not interleukin-1 beta gene polymorphism is associated with polycystic ovary syndrome | Q80242252 | ||
| P433 | issue | 6 | |
| P921 | main subject | inflammation | Q101991 |
| polycystic ovary syndrome | Q500816 | ||
| polycystic ovary | Q5547896 | ||
| P304 | page(s) | 375-382 | |
| P577 | publication date | 2017-06-01 | |
| P1433 | published in | International Journal of Reproductive Biomedicine (Yazd, Iran) | Q27727296 |
| P1476 | title | Polycystic ovary syndrome and circulating inflammatory markers | |
| P478 | volume | 15 |
| Q55209426 | Effects of myo-inositol plus alpha-lactalbumin in myo-inositol-resistant PCOS women. |
| Q92071281 | Investigation Trp64Arg polymorphism of the beta 3-adrenergic receptor gene in nonobese women with polycystic ovarian syndrome |
| Q64074159 | Levels of circulating insulin cell-free DNA in women with polycystic ovary syndrome – a longitudinal cohort study |
| Q64090990 | Low-Dose Tacrolimus Prevents Dysregulated Peri-Conceptional Ovarian and Systemic Immune Cellular Homeostasis in Subjects with PCOS |
| Q92002757 | Single-cell reconstruction of follicular remodeling in the human adult ovary |
Search more.